Qi Liang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.

Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.

Journal: The Pediatric infectious disease journal

Published: February 18, 2026

Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two Months.

Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two Months.

Journal: Vaccines

Published: February 11, 2026

Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccines.

Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccines.

Journal: Expert review of vaccines

Published: February 04, 2026

Active Surveillance on Safety and Compliance of Freeze-dried Human Rabies Vaccine (Vero Cell) - Jiangsu Province, China, 2023-2024.

Active Surveillance on Safety and Compliance of Freeze-dried Human Rabies Vaccine (Vero Cell) - Jiangsu Province, China, 2023-2024.

Journal: China CDC weekly

Published: May 29, 2025

Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial.

Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: May 27, 2025

Optimizing the prevention of mother-to-child transmission of hepatitis B through integrated care models: a pilot study in Jiangsu Province, China.

Optimizing the prevention of mother-to-child transmission of hepatitis B through integrated care models: a pilot study in Jiangsu Province, China.

Journal: BMC public health

Published: September 14, 2024

Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10-60 years old.

Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10-60 years old.

Journal: Vaccine

Published: July 17, 2024

Epidemiological characteristics of three herpesviruses infections in children in Nanjing, China, from 2018 to 2023.

Epidemiological characteristics of three herpesviruses infections in children in Nanjing, China, from 2018 to 2023.

Journal: Frontiers in cellular and infection microbiology

Published: June 13, 2024

Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China.

Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China.

Journal: Infectious diseases and therapy

Published: March 05, 2024

Persistence of immunity in children aged 2 months and 7 months - 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine.

Persistence of immunity in children aged 2 months and 7 months - 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine.

Journal: Vaccine

Published: March 04, 2024

Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.

Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.

Journal: The Lancet. Infectious diseases

Published: December 03, 2023

Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.

Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.

Journal: Journal of global health

Published: September 08, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026